We don't know the valuation of NGIO. We don't know

We don't know the valuation of NGIO. We don't know much about the share structure. We know virtually nothing value wise about the public company we are merging NGIO other than Joe says it is valued so low it isn't "material" and we don't need to know. What are we giving up money wise and GNBT share wise/NGIO share wise to purchase this company? Did we overpay the way we did with Veneto? What does the dividend offer look like? Are we "rewarding loyal shareholders" based on a being past owners of stock and/ or ANYONE who buys stock all the way up until a certain point in the future? Will there be money raised for NGIO? Will that be via discounted common shares or a combination of shares and warrants? Are there GNBT shares involved? We lost out on Kiromic, what about the 2 companies that were discussed in the last CC?

All these things and more are important as you noted regarding the details. The PPS could go up substantially.

Also there may be some enrollment and safety data being posted regarding AE37/Keytruda study. Anything noteworthy can make a difference.